Some chemokines can also induce drug resistance or drug resistance mutations in tumor cells, affect the effect of tumor chemotherapy, and mediate the activation of multiple signal pathways such as rapamycin target protein (mTOR) and JAK/STAT [19, 20]. This evidence concerns the gene SOAT1 and neoplasm.